SEATTLE--(BUSINESS WIRE)--March 10, 2006--Targeted Genetics Corporation (Nasdaq:TGEN) today announced that it has obtained agreements from select institutional investors to purchase 12,791,611 shares of its common stock at a price of $0.39 per share in a registered direct offering. The closing of the offering is expected to take place on March 10, 2006, subject to satisfaction of customary closing conditions.
